Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus
British Journal of Clinical Pharmacology, 10/22/09
Sidharta PN et al. – The results of this study indicate that antagonism of the urotensin–II system does not influence insulin secretion or sensitivity or daily blood glucose levels in diet–treated patients with Type 2 diabetes.
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Nutritional supplements and serum lipids: Does anything work
Current Atherosclerosis Reports, 11/16/09
Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


